Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0014070 (
encephalomyelitis
)
13,017
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study was aimed at restoring decreased T-cell functions and reduced susceptibility to proteolipid apoprotein (PLP) induced-experimental allergic
encephalomyelitis
(EAE) in old mice with thymic hormones. Thymosin fraction 5 (TF-5) and serum thymic factor (
FTS
) had no significant in vitro and in vivo effect on proliferative responses to PLP and concanavalin A (Con A), and on EAE induction in young and old mice. These results suggest that decreased T-cell functions cannot be restored by these thymic hormones tested.
...
PMID:Effect of thymic hormones on induction of experimental allergic encephalomyelitis in old mice. 225 3
Acute experimental allergic
encephalomyelitis
(EAE) was induced in Hartley guinea pigs and Lewis rats, which were then treated with synthetic serum thymic factor (
FTS
). When a dose of 30 micrograms/100 g body weight of
FTS
was subcutaneously administered to the animals on days--1 (before inoculation), 4, 9 and 15 intermittently, clinical symptoms of acute EAE were suppressed. Histopathological evaluation showed that the severity of EAE in
FTS
-treated guinea pigs was less than in untreated guinea pigs. Immunohistochemical examination showed that the numbers of OX6+, W3/25+, W3/13+ and OX19+ cells in
FTS
-treated rats were less than in untreated rats and that the number of OX8+ cells in
FTS
-treated rats was greater than in untreated rats. These findings suggest that
FTS
induced OX8+ cells in inflammatory lesions and suppressed inflammation in acute EAE.
...
PMID:Suppression of acute experimental allergic encephalomyelitis by synthetic serum thymic factor. Clinical, histopathological, and immunohistochemical studies. 283 9